[go: up one dir, main page]

TW200740440A - Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient - Google Patents

Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient

Info

Publication number
TW200740440A
TW200740440A TW095123932A TW95123932A TW200740440A TW 200740440 A TW200740440 A TW 200740440A TW 095123932 A TW095123932 A TW 095123932A TW 95123932 A TW95123932 A TW 95123932A TW 200740440 A TW200740440 A TW 200740440A
Authority
TW
Taiwan
Prior art keywords
medicaments
agonists
treatment
active ingredient
additional active
Prior art date
Application number
TW095123932A
Other languages
Chinese (zh)
Inventor
Ingo Konetzki
Thierry Bouyssou
Sabine Pestel
Andreas Schnapp
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of TW200740440A publication Critical patent/TW200740440A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to new medicament combinations which contain in addition to one or more, preferably one compound of general formula 1, wherein the groups X, Ra, Rb, R1, R1', R2, R2', R2", R2''', V and n may have the meanings given in the claims and in the specification, at least one other active substance 2, processes for preparing them and their use as pharmaceutical compositions.
TW095123932A 2005-07-01 2006-06-30 Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient TW200740440A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030733A DE102005030733A1 (en) 2005-07-01 2005-07-01 New drug combinations for the treatment of respiratory diseases containing long-acting beta-2 agonists and at least one other active ingredient

Publications (1)

Publication Number Publication Date
TW200740440A true TW200740440A (en) 2007-11-01

Family

ID=37087177

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095123932A TW200740440A (en) 2005-07-01 2006-06-30 Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient

Country Status (9)

Country Link
US (1) US20070037781A1 (en)
EP (1) EP1901776B1 (en)
JP (1) JP2009500310A (en)
AR (1) AR054810A1 (en)
AT (1) ATE546159T1 (en)
CA (1) CA2613828A1 (en)
DE (1) DE102005030733A1 (en)
TW (1) TW200740440A (en)
WO (1) WO2007003554A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035893A1 (en) * 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
CN102264745B (en) * 2008-11-10 2015-07-22 财团法人卫生研究院 Fused bicyclic and polycyclic pyrimidines as tyrosine kinase inhibitors
JP2014532063A (en) * 2011-10-12 2014-12-04 テリジェン リミテッドＴｅｌｉｇｅｎｅ Ｌｔｄ Quinazoline derivatives as kinase inhibitors and methods of use thereof
US9498458B2 (en) * 2014-06-02 2016-11-22 Medicinova, Inc. Method of inhibiting or treating fibrosis
US10487093B2 (en) * 2016-02-08 2019-11-26 Redx Pharma Plc Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
EP3488851A1 (en) * 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (en) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim AMINOALKYLHETEROCYCLES
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
GB2178965B (en) 1985-07-30 1988-08-03 Glaxo Group Ltd Devices for administering medicaments to patients
SE453566B (en) 1986-03-07 1988-02-15 Draco Ab POWDER INHALATOR DEVICE
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (en) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Capsule holder
DE19536902A1 (en) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Miniature fluid pressure generating device
HUP0103160A3 (en) * 1998-08-26 2002-11-28 Smithkline Beecham Corp Pharmaceutical compositions for treating pulmonary diseases containing pde4 inhibitor
CA2425539C (en) 2000-10-12 2007-04-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition
DE10050995A1 (en) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New benzylic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
DE10050994A1 (en) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease
HUP0400333A3 (en) 2001-06-22 2012-10-29 Boehringer Ingelheim Pharma Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition
DE10203749A1 (en) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma New anticholinergics, process for their preparation and their use as medicines
DE10203753A1 (en) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma New xanthene carboxylic acid esters, processes for their preparation and their use as medicines
DE10203741A1 (en) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma New fluorene carboxylic acid esters, process for their preparation and their use as medicaments
DE10246374A1 (en) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg New 4-(2-alkylamino-1-hydroxyethyl)-3-alkoxy-benzene-1,2-diol derivatives, are beta-mimetics having a long duration of action, useful e.g. for treating asthma, chronic obstructive pulmonary disease or arrhythmia
DE10253282A1 (en) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE60321953D1 (en) * 2002-11-27 2008-08-14 Nycomed Gmbh NEW SYNERGISTIC COMPOSITION CONTAINING ROFLUMILAST AND FORMOTEROL
JP2007500676A (en) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Inhalable drugs including anticholinergics and beta receptor stimulants
CA2534693A1 (en) * 2003-08-05 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and a betamimetic
DE102004003428A1 (en) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg New long-acting beta-2 agonists, and their use as pharmaceuticals

Also Published As

Publication number Publication date
ATE546159T1 (en) 2012-03-15
EP1901776A1 (en) 2008-03-26
CA2613828A1 (en) 2007-01-11
WO2007003554A1 (en) 2007-01-11
EP1901776B1 (en) 2012-02-22
DE102005030733A1 (en) 2007-01-04
JP2009500310A (en) 2009-01-08
AR054810A1 (en) 2007-07-18
US20070037781A1 (en) 2007-02-15

Similar Documents

Publication Publication Date Title
TW200634003A (en) Chemical compounds
MY143565A (en) Novel fluorocglycoside derivatives of pyrazoles: medicaments containing these compounds, and the use thereof
TW200616974A (en) Chemical compounds
TW200635899A (en) Chemical compounds
TW200621777A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
TW200736234A (en) Chemical compounds
MX2007008924A (en) Chemical compounds.
UA86614C2 (en) Compound having kinase ingibitor activity, pharmaceutical composition containing thereof and use thereof for the preparation of medicine
MY143795A (en) Tetrahydropyridoindole derivatives
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
UA85708C2 (en) Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases
TW200510392A (en) Chemical compounds
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
GB0415365D0 (en) Pyrimidine derivatives
TW200833670A (en) Novel compounds 569
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
WO2005037798A3 (en) Amide or thiomide derivatives and their use in the treatment of pain
MX2009008084A (en) 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors.
TW200621259A (en) Chemical compounds
TW200505452A (en) Chemical compounds
MX2009006010A (en) Amine derivatives and their use in beta-2-adrenoreceptor mediated diseases.
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
MY148945A (en) Combination of a betamimetic with anticholinergics and/or steroids